Mandibular Bisphosphonate-Related Osteonecrosis After Dental Implant Rehabilitation: A Case Report
National Council of Scientific and Technological Development (CNPq)
National Council of Scientific and Technological Development (CNPq)
CNPq (Brazil)
CNPq (Brazil)
Published in Osteoporosis International
SummaryIn an open-label extension study, BMD increased continuously with strontium ranelate over 10 years in osteoporotic women (P
Published in Physical chemistry chemical physics : PCCP
We describe an innovative multimodal system, which combines magnetic targeting of therapeutic agents with both magnetic resonance and fluorescence imaging into one system. This new magnetic nanoplatform consists of superparamagnetic γFe(2)O(3) nanoparticles, used clinically as an MRI contrast agent, conjugated to therapeutic molecules of the hydrox...
Osteoporotic patients treated with antiresorptive or anabolic agents experience an increase in bone mass and a reduction in incident fractures. However, the effects of these medications on bone quality and strength after a prolonged discontinuation of treatment are not known. We evaluated these effects in an osteoporotic rat model. Six-month-old ov...
OBJECTIVES: To assess the efficacy of once-yearly zoledronic acid (ZOL) 5 mg in increasing bone mineral density (BMD) in men with a recent hip fracture participating in the Health Outcomes and Reduced Incidence with Zoledronic Acid Once-Yearly Recurrent Fracture Trial and to compare the efficacy with that in women from the same study. DESIGN: Rando...
National Institute of Dental and Craniofacial Research (NIDCR/NIH)[DE-019917]
National Institute of Dental and Craniofacial Research (NIDCR/NIH)[DE-019917]
National Institute of Dental and Craniofacial Research (NIDCR/NIH)[DE-019917]